Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

17.94 -0.41 (-2.23%)
Streaming Delayed Price Updated: 1:59 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Unpacking Q2 Earnings: Elanco (NYSE:ELAN) In The Context Of Other Pharmaceuticals Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Elanco (NYSE:ELAN) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Why Elanco (ELAN) Stock Is Trading Up Today
Shares of animal health company Elanco (NYSE:ELAN) jumped 4.4% in the morning session after the company announced it will be joining the S&P MidCap 400 index. 
Via StockStory
Topics Artificial Intelligence Stocks
Stock Market Today: Dow, S&P 500 Futures Tick Up As Wall Street Awaits Nvidia Earnings— MongoDB, nCino, Snowflake In Focus
 
Via Benzinga
Topics Stocks
1 Healthcare Stock for Long-Term Investors and 2 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
Earnings Scheduled For August 7, 2025
 
Via Benzinga
P/E Ratio Insights for Elanco Animal Health
 
Via Benzinga
ELAN Q2 Deep Dive: Innovation and Execution Drive Raised Full-Year Outlook
Animal health company Elanco (NYSE:ELAN) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 4.8% year on year to $1.24 billion. Guidance for next quarter’s revenue... 
Via StockStory
5 Analysts Have This To Say About Elanco Animal Health
 
Via Benzinga
Elanco (NYSE:ELAN) Delivers Impressive Q2, Stock Jumps 15.4%
Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.8% year on year to $1.24 billion. Guidance for next quarter’s revenue was... 
Via StockStory
Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook
Elanco beats Q2 expectations and raises 2025 guidance as strong Pet Health sales and FX tailwinds offset tariff and investment impacts. 
Via Benzinga
Topics World Trade
What Does the Market Think About Elanco Animal Health?
 
Via Benzinga
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Elanco Animal Health Inc (NYSE:ELAN) Surpasses Q2 Estimates and Lifts Full-Year Guidance
Elanco Animal Health beats Q2 2025 estimates with $1.241B revenue and $0.26 EPS, raises full-year outlook, driving investor optimism. Shares up 3% pre-market. 
Via Chartmill
Elanco (ELAN) Q2 Revenue Jumps 5%
Via The Motley Fool
What To Expect From Elanco’s (ELAN) Q2 Earnings
Animal health company Elanco (NYSE:ELAN) will be reporting results this Thursday before market open. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
Why Elanco (ELAN) Stock Is Trading Up Today
Shares of animal health company Elanco (NYSE:ELAN) jumped 3% in the pre-market session after the company received approval from the European Commission for its canine dermatitis treatment, Zenrelia. 
Via StockStory
Topics Artificial Intelligence
Demystifying Elanco Animal Health: Insights From 5 Analyst Reviews
 
Via Benzinga
This Mondelez International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
 
Via Benzinga
1 Volatile Stock with Exciting Potential and 2 to Question
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
3 Profitable Stocks Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
The Analyst Verdict: Elanco Animal Health In The Eyes Of 4 Experts
 
Via Benzinga
Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise
Elanco upgraded to Outperform by William Blair as pipeline gains traction and EMA backs Zenrelia ahead of expected Q3 approval. 
Via Benzinga
This Truist Financial Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
 
Via Benzinga
3 Unpopular Stocks Facing Headwinds
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty
Animal health company Elanco (NYSE:ELAN) reported Q1 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $1.19 billion. The company’s full-year revenue... 
Via StockStory
Topics World Trade
2 Momentum Stocks with Impressive Fundamentals and 1 to Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
What's Driving the Market Sentiment Around Elanco Animal Health?
 
Via Benzinga
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Elanco (ELAN) Stock Trades Up, Here Is Why
Shares of animal health company Elanco (NYSE:ELAN) jumped 21.2% in the afternoon session after the company reported decent first quarter 2025 results which beat analysts' EPS expectations and included... 
Via StockStory
Topics Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.